Life Sciences Logistics Provider Expands into China
The Life Sciences logistics solutions provider, Biocair has recently expanded its operations into China. The opening ceremony, held on November 12th was attended by Carma Eliott, the British Consul General in Shanghai, who cut the ribbon together with Andy King, the Managing Director of Biocair. The British Consul general congratulated Biocair on the issue of their new Chinese Business Licence. She re-affirmed the British Government’s support of the Life Sciences sector and acknowledged the vital logistics role for research materials and clinical trial samples that Biocair can now provide companies in China.
Biocair, established since 1987, is a proven international specialist in transporting temperature sensitive biological materials and drugs for clinical trials in and out of the main pharmaceutical and biopharmaceutical clusters in UK, Europe, USA, South America, Russia, Japan, and India. The new logistics operation in Shanghai has extended their Asia service offering. Andy King commented; “This expansion into China is a key step in our international business development plan in response to growing customer demand in the region”. He went on to say: “We really appreciated all the encouragement and support we have had from customers, which helped us make this investment decision to enter the China market.”
Biocair used the consultancy company Asiasetup to assist in setting up operations in China. Asiasetup was able to gain ‘Wholly Foreign Owned Enterprise’ approval at Municipal level in two weeks and Biocair’s business license was granted two weeks later.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
